Utilización de drogas antiepilépticas en pediatría

1. Weijenberg A, Offringa M, Brouwer OF, et al. RCTs with new antiepileptic drugs in children: a systematic review of monotherapy studies and their methodology. Epilepsy Res 2010; 91:1–9.

2. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, Lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1000–15.

3. Kimland E, Rane A, Ufer M, et al. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001. Pharmacoepidemiol Drug Saf 2005;14:493–9.

4. Loke YK. Use of databases for clinical research. Arch Dis Child 2014;99:587–9.

5. Clavenna A, Bonati M. Differences in antibiotic prescribing in paediatric outpatients. Arch Dis Child 2011;96:590–5.

6. Clavenna A, Bonati M. Drug prescriptions to outpatient children: a review of the literature. Eur J Clin Pharmacol 2009;65:749–55.

7. van de Vrie-Hoekstra NW, de Vries TW, van den Berg PB, et al. Antiepileptic drug utilization in children from 1997-2005--a study from the Netherlands. Eur J Clin Pharmacol 2008;64:1013–20.

8. Hsieh LP, Huang CY. Trends in the use of antiepileptic drugs in Taiwan from 2003 to 2007: a population-based national health insurance study. Epilepsy Res 2011;96:81–8.

9. Nicholas JM, Ridsdale L, Richardson MP, et al. Trends in antiepileptic drug utilisation in UK primary care 1993-2008: cohort study using the General Practice Research Database. Seizure 2012;21:466–70.

10. Kwong KL, Tsui KW, Wu SP, et al. Utilization of antiepileptic drugs in Hong Kong children. Pediatr Neurol 2012;46:281–6.

11. Tan WW, Kong ST, Chan DW, et al. A retrospective study on the usage of antiepileptic drugs in asian children from 2000 to 2009 in the largest pediatric hospital in Singapore. Pharmacoepidemiol Drug Saf 2012;21:1074–80.

12. Pickrell WO, Lacey AS, Thomas RH, et al. Trends in the first antiepileptic drug prescribed for epilepsy between 2000 and 2010. Seizure 2014;23:77–80.

13. Landmark CJ, Fossmark H, Larsson PG, et al. Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population. Epilepsy Res 2011;95:51–9.

14. Bourgeois FT, Olson KL, Poduri A, et al. Comparison of drug utilization patterns in Observational Data: antiepileptic drugs in Pediatric Patients. Paediatr Drugs 2015;17:401–10.

15. Lee SY, Jung KY, Lee IK, et al. Prevalence of treated epilepsy in Korea based on national health insurance data. J Korean Med Sci 2012;27:285–90.

16. National Institute for Health and Clinical Excellence. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care, 2012. Available from. guidance.nice.org.uk/cg137.

17. Putignano D, Clavenna A, Campi R, et al. Antiepileptic drug use in italian children over a decade. Eur J Clin Pharmacol 2017;73:241–8.

18. Amstutz U, Shear NH, Rieder MJ, et al. Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions. Epilepsia

2014;55:496–506.

19. Leckband SG, Kelsoe JR, Dunnenberger HM, et al. Clinical pharmacogenetics implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing. Clin Pharmacol Ther 2013;94:324–8.

20. Yan W ZL. Utilization of antiepileptic drugs on Monotherapy and Polytherapy for Children at Shanghai in China. Int JPharmacol 2016;12:496–504.

21. Chen CB, Hsiao YH, Wu T, et al. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians. neurology 2017;88:78–86.

22. Hung SI, Chung WH, Liu ZS, et al. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics